Evidence map›Paper›PMID 26601949›Full record

ArticleThe Journal of biological chemistry2016

1α,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells.

Zachary C Ryan, Theodore A Craig, Clifford D Folmes, Xuewei Wang, Ian R Lanza, Niccole S Schaible, Jeffrey L Salisbury, K Sreekumaran Nair, Andre Terzic, Gary C Sieck and 1 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 6 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 6 syntheses or guidelines pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Epigenetic Mechanisms of Vitamin D in the Aging Process: A Narrative Review.International journal of molecular sciences · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zachary C RyanFrom the Departments of Medicine.
Theodore A CraigFrom the Departments of Medicine.
Clifford D FolmesFrom the Departments of Medicine.
Xuewei WangHealth Sciences Research.
Ian R LanzaFrom the Departments of Medicine.
Niccole S SchaiblePhysiology and Biomedical Engineering, and.
Jeffrey L SalisburyBiochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
K Sreekumaran NairFrom the Departments of Medicine.
Andre TerzicFrom the Departments of Medicine.
Gary C SieckPhysiology and Biomedical Engineering, and.
Rajiv KumarFrom the Departments of Medicine, Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905 rkumar@mayo.edu.
Mayo Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
MECHANISM OF MUSCLE WASTING IN AGING MANR01AG009531 · NIA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI NAIR, K SREEKUMARAN · 1993 to 2014
$8.8M
Live Unrelated Kidney Donor & Sibling Follow-up StudyU01DK066013 · NIDDK · UNIVERSITY OF MINNESOTA · PI KASISKE, BERTRAM L · 2006 to 2016
$5.9M
Role of Mitochondria in Airway Smooth MuscleR01HL126451 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2015 to 2018
$1.9M
Live Unrelated Kidney Donor &Sibling Follow-up StudyR01DK066013 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI KASISKE, BERTRAM L · 2005 to 2005
$558k
Metabolic reprogramming in pluripotent induction and cardiac lineage specificatioK99HL121079 · NHLBI · MAYO CLINIC ROCHESTER · PI FOLMES, CLIFFORD D · 2014 to 2015
$279k
NCATS NIH HHS UL1 TR000135NHLBI NIH HHS HL126451NHLBI NIH HHS K99 HL121079NHLBI NIH HHS R01 HL126451NIA NIH HHS AG009531NIA NIH HHS R01 AG009531NIDDK NIH HHS DK066013NIDDK NIH HHS R01 DK066013NIDDK NIH HHS U01 DK066013
6 · The paper itself

Abstract

Muscle weakness and myopathy are observed in vitamin D deficiency and chronic renal failure, where concentrations of the active vitamin D3 metabolite, 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3), are low. To evaluate the mechanism of action of 1α,25(OH)2D3 in skeletal muscle, we examined mitochondrial oxygen consumption, dynamics, and biogenesis and changes in expression of nuclear genes encoding mitochondrial proteins in human skeletal muscle cells following treatment with 1α,25(OH)2D3. The mitochondrial oxygen consumption rate (OCR) increased in 1α,25(OH)2D3-treated cells. Vitamin D3 metabolites lacking a 1α-hydroxyl group (vitamin D3, 25-hydroxyvitamin D3, and 24R,25-dihydroxyvitamin D3) decreased or failed to increase OCR. 1α-Hydroxyvitamin D3 did not increase OCR. In 1α,25(OH)2D3-treated cells, mitochondrial volume and branching and expression of the pro-fusion protein OPA1 (optic atrophy 1) increased, whereas expression of the pro-fission proteins Fis1 (fission 1) and Drp1 (dynamin 1-like) decreased. Phosphorylated pyruvate dehydrogenase (PDH) (Ser-293) and PDH kinase 4 (PDK4) decreased in 1α,25(OH)2D3-treated cells. There was a trend to increased PDH activity in 1α,25(OH)2D3-treated cells (p = 0.09). 83 nuclear mRNAs encoding mitochondrial proteins were changed following 1α,25(OH)2D3 treatment; notably, PDK4 mRNA decreased, and PDP2 mRNA increased. MYC, MAPK13, and EPAS1 mRNAs, which encode proteins that regulate mitochondrial biogenesis, were increased following 1α,25(OH)2D3 treatment. Vitamin D receptor-dependent changes in the expression of 1947 mRNAs encoding proteins involved in muscle contraction, focal adhesion, integrin, JAK/STAT, MAPK, growth factor, and p53 signaling pathways were observed following 1α,25(OH)2D3 treatment. Five micro-RNAs were induced or repressed by 1α,25(OH)2D3. 1α,25(OH)2D3 regulates mitochondrial function, dynamics, and enzyme function, which are likely to influence muscle strength.

Indexed as

Gene Expression RegulationMitochondrial DynamicsOxidative PhosphorylationCalcitriolCells, CulturedGene Expression ProfilingGreen Fluorescent ProteinsGTP PhosphohydrolasesHumansMicroRNAsMitochondria, MuscleMuscle, SkeletalPhosphorylationProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseCalcitriolenhanced green fluorescent proteinGreen Fluorescent ProteinsGTP PhosphohydrolasesMicroRNAsOPA1 protein, humanPDK4 protein, humanProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinasePyruvate Dehydrogenase (Lipoamide)-PhosphataseReceptors, CalcitriolRecombinant Fusion ProteinsVDR protein, human1,25-dihydroxyvitamin D3cell signalinggene expressionmitochondriaoxygen consumptionRNA-seqskeletal musclevitamin DWTSS

Identifiers

PMID26601949
PMCPMC4714233
OpenAlexW2179748167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.